T1	Participants 531 700	healthy children aged 6 months to 5 years to receive 25 mg/kg sulfadoxine and 1.25 mg/kg pyrimethamine plus either placebo, 25 mg/kg amodiaquine, or 12 mg/kg artesunate.
T2	Participants 701 713	Participants
T3	Participants 1110 1139	183 (61%) of 316 participants
T4	Participants 1432 1463	sulfadoxine/pyrimethamine group
T5	Participants 1506 1554	sulfadoxine/pyrimethamine plus amodiaquine group
T6	Participants 1585 1632	sulfadoxine/pyrimethamine plus artesunate group
T7	Participants 1844 1886	sulfadoxine/pyrimethamine plus amodiaquine
T8	Participants 1699 1747	sulfadoxine/pyrimethamine plus amodiaquine group
T9	Participants 1683 1691	patients
T10	Participants 1827 1834	groups.
T11	Participants 2120 2162	Sulfadoxine/pyrimethamine plus amodiaquine
T12	Participants 2062 2103	sulfadoxine/pyrimethamine plus artesunate
